Literature DB >> 7505168

The proximal region of the MBP gene promoter is sufficient to induce oligodendroglial-specific expression in transgenic mice.

C Goujet-Zalc1, C Babinet, M Monge, S Timsit, F Cabon, A Gansmüller, M Miura, M Sanchez, S Pournin, K Mikoshiba, B Zalc.   

Abstract

To characterize regulatory DNA sequences involved in oligodendroglial expression of myelin basic protein (MBP), transgenic mice carrying a 256 bp fragment of the mouse MBP promoter fused to an Escherichia coli lacZ gene were generated. Of four transgenic families, two (lines 2 and 4) expressed beta-galactosidase activity in the nervous system but not in most other tissues. Histochemical and immunohistochemical analysis of adult brain from these two lines showed oligodendroglial-specific expression of the transgene. In line 2, only a small proportion of oligodendrocytes expressed the transgene, and in labelled cells the product of the enzymatic reaction with beta-galactosidase was confined to a small round vesicle in the vicinity of the nucleus. In contrast, in tissue sections from line 4 adult brain and spinal cord beta-galactosidase activity was much more intense and at least 80-90% of oligodendrocytes expressed the transgene. Detection of the MBP-lacZ transcript by in situ hybridization showed that the transgene mRNA was confined to the oligodendrocyte cell body. These results suggest that cis-acting regulatory elements, specifying oligodendrocytes identity, are located within 256 bp upstream from the MBP gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505168     DOI: 10.1111/j.1460-9568.1993.tb00528.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

1.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10.

Authors:  C Claus Stolt; Stephan Rehberg; Marius Ader; Petra Lommes; Dieter Riethmacher; Melitta Schachner; Udo Bartsch; Michael Wegner
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

2.  A distal upstream enhancer from the myelin basic protein gene regulates expression in myelin-forming schwann cells.

Authors:  R Forghani; L Garofalo; D R Foran; H F Farhadi; P Lepage; T J Hudson; I Tretjakoff; P Valera; A Peterson
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

3.  A transgenic mouse model for inducible and reversible dysmyelination.

Authors:  C Mathis; C Hindelang; M LeMeur; E Borrelli
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 4.  Axonal signals and oligodendrocyte differentiation.

Authors:  Maura Bozzali; Lawrence Wrabetz
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

5.  Evidence that the homeodomain protein Gtx is involved in the regulation of oligodendrocyte myelination.

Authors:  R Awatramani; S Scherer; J Grinspan; E Collarini; R Skoff; D O'Hagan; J Garbern; J Kamholz
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

6.  Embryonic expression of the myelin basic protein gene: identification of a promoter region that targets transgene expression to pioneer neurons.

Authors:  C F Landry; T M Pribyl; J A Ellison; M I Givogri; K Kampf; C W Campagnoni; A T Campagnoni
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

7.  Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.

Authors:  Andrew V Caprariello; Saisho Mangla; Robert H Miller; Stephen M Selkirk
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

8.  The control of reactive oxygen species production by SHP-1 in oligodendrocytes.

Authors:  Ross C Gruber; Daria LaRocca; Scott B Minchenberg; George P Christophi; Chad A Hudson; Alex K Ray; Bridget Shafit-Zagardo; Paul T Massa
Journal:  Glia       Date:  2015-04-27       Impact factor: 7.452

9.  Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.

Authors:  Andrew V Caprariello; Courtney E Batt; Ingrid Zippe; Rita R Romito-DiGiacomo; Molly Karl; Robert H Miller
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

10.  Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells.

Authors:  Y Miyao; K Shimizu; M Tamura; H Akita; K Ikeda; E Mabuchi; H Kishima; T Hayakawa; K Ikenaka
Journal:  Jpn J Cancer Res       Date:  1997-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.